Gábor Heltovics

Gábor Heltovics is a Venture Partner at NLC, a European Healthtech Venture Builder based in the Netherlands.

Gábor is a Life Science and Biotech leader with 20+ years diverse experience in emerging and large life science, biotech and pharma companies with a functionally and geographically broad background. Gábor’s competence includes building effective, externally focused organizations, raising capital and developing clinical and research product pipelines from small start-up to multinational, integrated clinical stage pharma companies.

Key areas of expertise include advanced technology platform innovation, business development and asset in-licensing, research and development in oncology, pain, ED, rare diseases, orphan drugs, proctology, CF and infectious diseases.

In his most recent endeavor, he was the CEO of a specialty biopharmaceutical company, Tavanta Therapeutics. Under Gábor’s guidance, Tavanta secured over $55 million in funding and grew from a 2-person company to an organization with five pivotal clinical stage compounds for major indications such as oncology and pain, as well as an innovative pre-clinical pipeline following closely.